Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study-Reference-Cited by-同舟云学术

Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study

Published:2014-03-18 Issue:11 Volume:120 Page:1686-1694
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

McQuilten Zoe K.¹²,Wood Erica M.¹,Polizzotto Mark N.¹,Campbell Lynda J.³⁴,Wall Meaghan³,Curtis David J.⁵,Farrugia Helen⁶,McNeil John J.¹,Sundararajan Vijaya⁴⁷

Affiliation:

1. Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Australia

2. Research and Development, Australian Red Cross Blood Service; Melbourne Australia

3. Victorian Cancer Cytogenetics Service, St Vincent's Hospital; Melbourne Australia

4. Department of Medicine; University of Melbourne; St Vincent's Hospital Melbourne Australia

5. Australian Centre for Blood Diseases; Monash University; Melbourne Australia

6. Victorian Cancer Registry; Melbourne Australia

7. Department of Medicine; Southern Clinical School, Monash University; Melbourne Australia

Funder

NHMRC

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28641/fullpdf

Reference42 articles.

1. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs;Rollison;Blood,2008

2. Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need;Goldberg;Transfusion,2012

3. Establishing the incidence of myelodysplastic syndrome;Williamson;Br J Haematol,1994

4. Epidemiological characteristics of myelodysplastic syndrome in a well-defined French population;Maynadie;Br J Cancer,1996

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct Clinical and Prognostic Features of Myelodysplastic Syndrome in Patients from the Middle East, North Africa, and Beyond: A Systemic Review;Journal of Clinical Medicine;2023-04-12

2. Treatment patterns in older patients with myelodysplastic syndromes: A population-based analysis reflecting the real world;Journal of Geriatric Oncology;2023-03

3. Epidemiologic outlook of therapy‐related myeloid neoplasms and selection of high‐risk patients: A Korean nationwide study;Cancer;2022-09-07

4. Myelodysplastic Syndrome/Acute Myeloid Leukemia Following the Use of Poly-ADP Ribose Polymerase (PARP) Inhibitors: A Real-World Analysis of Postmarketing Surveillance Data;Frontiers in Pharmacology;2022-06-15

5. Incidence of myelodysplastic syndromes in Finland 1997–2016;Leukemia Research;2022-05